Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 4/20 | 0.47 |
| ▸ | ITGA2B | P08514 | 4/20 | 0.47 |
| ▸ | NPY4R | P50391 | 6/20 | 0.40 |
| ▸ | NPY5R | Q15761 | 5/20 | 0.40 |
| ▸ | NPY1R | P25929 | 4/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 4/20 | 0.40 |
| ▸ | NPY2R | P49146 | 2/20 | 0.40 |
| ▸ | PLA2G10 | O15496 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7355927 | 1.00 | ITGB3 (0.47) | ITGB3ITGA2BNPY4RNPY5RNPY1R | |
| SCHEMBL7349462 | 0.92 | EPHX2 (0.41) | ITGB3ITGA2BNPY4RNPY5RNPY1R | |
| SCHEMBL7349426 | 0.92 | EPHX2 (0.41) | ITGB3ITGA2BNPY4RNPY5RNPY1R | |
| SCHEMBL7348675 | 0.92 | EPHX2 (0.41) | ITGB3ITGA2BNPY4RNPY5RNPY1R | |
| SCHEMBL7347873 | 0.92 | EPHX2 (0.41) | ITGB3ITGA2BNPY4RNPY5RNPY1R | |
| SCHEMBL7350352 | 0.92 | EPHX2 (0.41) | ITGB3ITGA2BNPY4RNPY5RNPY1R | |
| SCHEMBL7355782 | 0.92 | EPHX2 (0.41) | ITGB3ITGA2BNPY4RNPY5RNPY1R | |
| SCHEMBL7349234 | 0.92 | EPHX2 (0.41) | ITGB3ITGA2BNPY4RNPY5RNPY1R | |
| SCHEMBL7348479 | 0.92 | EPHX2 (0.41) | ITGB3ITGA2BNPY4RNPY5RNPY1R | |
| SCHEMBL7353580 | 0.92 | EPHX2 (0.41) | ITGB3ITGA2BNPY4RNPY5RNPY1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1998043962-A1 | HETEROCYCLIC INTEGRIN INHIBITOR PRODRUGS | DU PONT PHARMACEUTICALS COMPANY (US) | 1998-10-08 | — | — | WO | claimed |
| WO-1993011759-A1 | ANTITHROMBOTIC DIAMINOALKANOIC ACID DERIVATIVES | RHONE-POULENC RORER INTERNATIONAL (HOLDINGS) INC. (US) | 1993-06-24 | — | — | WO | disclosed |